Retatrutide
10 mg · ≥98.9% · Lot 26·06
$110
Lab tested · COA available
Free shipping over $99
Discreet packaging
Retatrutide is a next-generation triple-agonist peptide that simultaneously engages GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon (GCGR) receptors. This tri-receptor mechanism represents an advancement over single and dual-agonist compounds studied in metabolic research. Preclinical and early clinical data suggest enhanced effects on energy expenditure, lipid metabolism, and glycaemic regulation compared to mono-agonist approaches. The glucagon receptor component adds a thermogenic and lipolytic dimension not present in earlier incretin-class peptides. Each vial contains 10 mg at ≥98.9% purity verified by HPLC.
Category: Metabolic
Purity: ≥98.9%
Quantity: 10 mg per vial
Format: Lyophilized powder
Add 1-2 mL of bacteriostatic water. Swirl gently — do not shake. Solution should be clear and colourless.
Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2-8°C and use within 30 days.
Ships from Chilliwack, BC via Xpresspost. 2-3 business day delivery. Discreet, insulated packaging.
IncretinLab
May 25, 2026
Triple agonist is difficult to source. PepSupply's batch passed all our QC checks.
M. Taylor
May 10, 2026
Clean lyophilized cake. Our receptor binding assays confirm activity at all three targets.
Dr. F.H.
Apr 24, 2026
Good purity for the price. Would be great to see 20mg and 60mg options.
MetaStudies
Apr 7, 2026
Comparing this to dual agonists in our models. The GCGR component adds clear thermogenic signal.
P. Roy
Mar 21, 2026
Fast shipping, properly cold-packed. Product matches published characterisation data.
Your cart is empty.
